Mirion Technologies, Inc. MIR

Company Overview

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions serving the nuclear energy, medical, defense, scientific research, and industrial markets. The company operates primarily in the radiation safety and nuclear instrumentation industries, with products and services designed to support radiation protection, dosimetry, imaging quality assurance, nuclear measurement, and reactor safety. Mirion generates revenue through the sale of radiation monitoring hardware, software platforms, recurring service contracts, calibration services, and long-term support agreements with regulated industries and government agencies.

The company’s principal business lines are organized around nuclear and safety technologies and medical technologies. Its customer base includes nuclear utilities, hospitals, cancer treatment centers, laboratories, defense agencies, and industrial operators requiring radiation detection and compliance solutions. Mirion’s positioning is supported by its installed base within highly regulated environments, long product qualification cycles, and technical expertise in radiation-sensitive applications. The company traces its origins to Mirion, founded in 1955, and expanded significantly through acquisitions over several decades. In 2021, Mirion became publicly traded through a merger with GS Acquisition Holdings Corp II, a special purpose acquisition company.

Business Operations

Mirion operates through two primary reporting segments: Nuclear & Safety and Medical. The Nuclear & Safety segment provides radiation monitoring systems, nuclear instrumentation, reactor safety technologies, dosimetry services, and contamination monitoring solutions used across nuclear power plants, government agencies, defense programs, research laboratories, and industrial settings. The Medical segment supplies radiation oncology quality assurance systems, diagnostic imaging products, occupational dosimetry, and related software for healthcare providers and cancer treatment facilities. Revenue is generated through equipment sales, software licensing, maintenance contracts, calibration services, and recurring dosimetry programs.

The company maintains operations across North America, Europe, and Asia, with manufacturing, engineering, and service capabilities distributed internationally. Mirion controls a portfolio of proprietary radiation detection technologies, monitoring systems, and analytical software platforms used in mission-critical and regulated applications. Major subsidiaries and brands include Canberra, Capintec, Sun Nuclear, and Mirion Medical. The company has also maintained relationships with nuclear utilities, healthcare systems, government agencies, and defense contractors through long-duration supply and service arrangements.

Strategic Position & Investments

Mirion’s strategic direction has focused on expanding its presence in nuclear safety, radiation monitoring, and oncology-related quality assurance markets. The company has pursued growth through both organic investment and acquisitions, particularly in medical physics and nuclear instrumentation. Management has emphasized recurring revenue streams, software-enabled solutions, and lifecycle service offerings tied to regulated infrastructure and healthcare systems. Industry trends supporting the company include renewed investment in nuclear energy, modernization of aging reactor fleets, radiation safety compliance requirements, and increasing global demand for cancer treatment technologies.

Mirion has completed multiple acquisitions to broaden its technology portfolio and geographic reach. Notable acquired businesses include Sun Nuclear Corporation, which strengthened the company’s radiation oncology quality assurance capabilities, and Canberra Industries, which expanded its nuclear measurement and instrumentation offerings. The company continues to invest in digital monitoring systems, data analytics, and integrated radiation intelligence platforms. Public filings and investor materials also indicate ongoing interest in advanced nuclear infrastructure, medical imaging support technologies, and defense-related radiation detection applications.

Geographic Footprint

Mirion is headquartered in Atlanta, Georgia, United States, and maintains operations across North America, Europe, and Asia-Pacific. The company serves customers in more than 100 countries through a combination of direct operations, manufacturing facilities, service centers, and distribution networks. Significant operational presence exists in the United States, France, Germany, Belgium, Finland, China, and the United Kingdom, reflecting the global nature of the nuclear and medical technology sectors it serves.

Internationally, Mirion supports commercial nuclear facilities, government nuclear programs, hospitals, and industrial operators across multiple continents. Its technologies are embedded in radiation-sensitive environments requiring regulatory compliance, long-term maintenance, and technical certification. The company’s global footprint provides exposure to both mature nuclear markets and regions investing in new reactor development, medical infrastructure expansion, and industrial safety modernization.

Leadership & Governance

Mirion’s leadership team combines experience in industrial technology, healthcare technology, nuclear systems, and regulated infrastructure operations. The company operates under a corporate governance structure typical of publicly traded U.S. companies and reports through filings including annual reports on Form 10-K and quarterly reports on Form 10-Q submitted to the U.S. Securities and Exchange Commission (SEC). Leadership strategy has emphasized operational execution, integration of acquired businesses, expansion of recurring revenues, and investment in high-reliability technologies serving mission-critical applications.

Key executives include:

• Thomas Logan – Chief Executive Officer
• Loic Eloy – President, Nuclear & Safety Division
• Brian Schopfer – President, Medical Division
• Emmanuelle Lee – Chief Financial Officer
• Maryann Malloy – Chief Human Resources Officer

Mirion’s governance and strategic direction are overseen by its board of directors and executive leadership team, with stated priorities centered on safety-focused innovation, operational discipline, and long-term participation in regulated end markets including nuclear power, healthcare, and defense.